DJIA 17,079.57 -42.44 -0.25%
NASDAQ 4,557.70 -11.93 -0.26%
S&P 500 1,996.74 -3.38 -0.17%
market minute promo

Celgene (NASDAQ: CELG)

94.70 -0.04 (-0.04%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

CELG $94.70 -0.04%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $94.00
Previous Close $94.74
Daily Range $93.75 - $95.25
52-Week Range $66.85 - $96.15
Market Cap $75.7B
P/E Ratio 54.76
Dividend (Yield) $0.00 (0.0%)
Volume 2,731,333
Average Daily Volume 4,210,840
Current FY EPS $3.18

Sector

Healthcare

Industry

Drugs

Celgene (CELG) Description

A biopharmaceutical company primarily engaged in the discovery, development and commercialization of innovative therapies designed to treat cancer and immune-inflammatory related diseases. Website: http://www.celgene.com/

News & Commentary

3 Reasons Celgene Corporation's Stock Could Fall

Celgene shares are up more than 1,200% over the past decade. But these three headwinds could be the brick wall that sends its stock lower.

Bristol-Myers' Oral HCV Treatment Daklinza Gets EU Clearance - Analyst Blog

#PreMarket Primer: Thursday, August 28: Russia Implicated Further In Ukrainian Conflict

#PreMarket Primer: Thursday, August 28: Russia Implicated Further In Ukrainian Conflict

Biotech Stock Roundup: Biotechs Surge on InterMune Acquisition Deal, Focus on More M&As - Analyst Bl

Biotech Stock Roundup: Biotechs Surge on InterMune Acquisition Deal, Focus on More M&As - Analyst Blog

Rising Short Interest in Biotech Stocks

New Lifetime High For Celgene (CELG)

The Best Hedge Fund You've Never Heard Of and Its Top 5 Stock Picks

Celgene (CELG): Today's Pre-Market Leader Stock

Why Celgene Stock Is Still A Good Investment Opportunity

See More CELG News...

CELG's Top Competitors

CELG $94.70 (-0.04%)
Current stock: CELG
$0.00 (0.00%)
Current stock:
AMGN $138.69 (0.62%)
Current stock: AMGN
BIIB $341.24 (-0.62%)
Current stock: BIIB